z-logo
open-access-imgOpen Access
Pulmonary Hypertension in Patient with Neurofibromatosis Type 1
Author(s) -
Yeong min Lee,
TaeHyun Yang,
Heesoo Jung,
Tae-Seon Oh,
Song Jeong-Hoon,
Seung-Jung Yu
Publication year - 2017
Publication title -
kosin medical journal
Language(s) - English
Resource type - Journals
eISSN - 2586-7024
pISSN - 2005-9531
DOI - 10.7180/kmj.2017.32.2.227
Subject(s) - medicine , neurofibromatosis , pulmonary hypertension , exertion , right heart catheterization , complication , endothelin receptor antagonist , family history , cardiology , cardiac catheterization , pediatrics , antagonist , surgery , radiology , receptor
Neurofibromatosis type 1 (NF1) is a rare genetic disease. Precapillary pulmonary hypertension (PH) with NF1 is an extremely severe complication. A 65-year-old woman was admitted in our hospital with 3-year history of gradually worsening dyspnea on exertion (New York Heart Association functional class III-IV). Considering her clinical feature and examination findings, she could be diagnosed as PH associated with NF1. She was treated with endothelin receptor antagonist. However her dyspnea was not significantly improved. This is the first Korean case of NF1 patient with PH which confirmed with right heart catheterization.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom